Abstract Background DNA methylation is a biomarker suited to investigate dynamic processes, such as treatment response. For this analysis we focus on DNA methylation changes during a randomised controlled trial (RCT) in treatment resistant depressed patients comparing racemic ketamine (s.c.) versus midazolam (s.c.) (the Ketamine for Adult Depression Study - KADS). This clinical trial showed a...